To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin
 +Metronidazole in outpatients with Pelvic Inflammatory Disease.

 Materials and Methods: Two hundred patients divided to two groups( A , B). Group A (treated
 by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine
 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy
Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. +
 Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole
 500mg) for 10 days, were compared in terms of side effects and efficacy
Inclusion Criteria:Eligibility criteria were having three out of five following symptoms:
 a-lower abdominal pain, b-vaginal discharges, c- adnexal tenderness, d-cervical motion
 tenderness (CMT), e-cervisitis.

 -

 Exclusion Criteria:Excluding criteria were as follows: a-unmarried women, b-pregnant women,
 c-women with infection during menstruation, d- history of abortion or miscarriage during
 the last month, e-underlying diseases such as diabetes, f-used antibiotics in the last
 month, or allergy to the antibiotics used in the study, g-history of Pelvic Inflammatory
 Disease within the last year, and h- suspicion of being multi partner.

 -